- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
December 5, 2024Jake Holdreith Named to Twin Cities Business Top 100
-
December 4, 2024Robins Kaplan Obtains $10.5 Million Post-Verdict in Landmark Aerosol Dust Remover Abuse Case
-
December 2, 2024Robins Kaplan LLP Announces 2025 Partners
-
December 11, 20242024 Year in Review: eDiscovery and Artificial Intelligence
-
December 12, 2024Strategies for Licensing AI: A Litigation Perspective
-
December 2024A Landmark Victory for Disabled Homeless Veterans: Q&A with the Trial Team
-
November 8, 2024Trademark tensions on the track: Court upholds First Amendment protections in Haas v. Steiner
-
November 8, 2024Destination Skiing And The DOJ's Mountain Merger Challenge
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Generic Launches
Fall 2017
Reference Listed Drug | NDA Holder | Generic Drug Name | ANDA Applicant(s) |
Indication | Launch Date |
---|---|---|---|---|---|
Focalin XR | Novartis | Dexmethylphenidate HCl ER Capsules | Impax Laboratories | used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older | 7/5/2017 |
Vigamox | Novartis | Moxifloxacin HCl Solution | Lupin | used for the treatment of bacterial conjunctivitis caused by susceptible strains of the organisms | 7/5/2017 |
Axiron | Eli Lilly | Testosterone Topical Solution | Perrigo | used for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone | 7/5/2017 |
Concerta | Janssen | Methylphenidate HCl ER Tablets | Impax Laboratories | used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 years and older | 7/17/2017 |
Renvela | Genzyme | Sevelamer Carbonate Tablets | Aurobindo Pharma USA | used for the control of serum phosphorus in patients with chronic kidney disease | 7/19/2017 |
Altace | Pfizer | Ramipril Capsules | Rising Pharmaceuticals | used for the treatment of hypertension | 7/21/2017 |
Cozaar | Merck | Losartan Potassium Tablets | Rising Pharmaceuticals | used for the treatment of hypertension | 7/21/2017 |
Hyzaar | Merck | Losartan Potassium / Hydrochlorothiazide Tablets | Rising Pharmaceuticals | used for the treatment of hypertension | 7/21/2017 |
Pravachol | Bristol-Myers Squibb | Pravastatin Tablets | Rising Pharmaceuticals | used as an adjunct to diets restricting saturated fats and cholesterol | 7/21/2017 |
Temodar | Schering | Temozolomide Capsules | Rising Pharmaceuticals | used for the treatment of adult patients with newly diagnosed glioblastoma multiforme | 7/21/2017 |
Zomig-ZMT | AstraZeneca | Zolmitriptan Orally Disintegrating Tablets | Rising Pharmaceuticals | used for the acute treatment of migraines | 7/21/2017 |
Cetirizine HCl Capsules (Softgel) (OTC) | Bionpharma | Cetirizine HCl Capsules (Softgel) (OTC) | Strides Shasun | used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives and itching | 7/24/2017 |
Vagifem | Novo Nordisk | Estradiol Vaginal Inserts | Teva | used for the treatment of atrophic vaginitis due to menopause | 7/24/2017 |
Robinul | Shionogi | Glycopyrrolate Tablets | Heritage Pharmaceuticals | used for adjunctive therapy in the treatment of peptic ulcer | 7/25/2017 |
Wellburin | GlaxoSmithKline | Bupropion Tablets | Heritage Pharmaceuticals | used for the treatment of depression | 7/25/2017 |
Epiduo | Galderma Laboratories | Adapalene / Benzoyl Peroxide Gel | Teva | used for the topical treatment of acne vulgaris in patients 9 years of age and older | 7/28/2017 |
Transderm Scop | Sandoz | Scopolamine 1.5 mg Transdermal System Patch | Perrigo | used for the prevention of nausea and vomiting associated with motion sickness and recovery from anesthesia after surgery in adults | 7/31/2017 |
Tamiflu | Roche | Oseltamivir Phosphate Capsules | Amneal | used to treat and prevent influenza A and influenza B (flu) | 8/8/2017 |
Roxicodone | Mallinckrodt | Oxycodone HCI Tablets | Camber Pharmaceuticals | used to help relieve moderate to severe pain | 8/17/2017 |
Ziagen | ViiV Healthcare | Abacavir Oral Solution | Camber Pharmaceuticals |
used in combination with other
antiretroviral agents for the treatment of HIV-1 infection
|
8/17/2017 |
Axiron | Eli Lilly | Testosterone Topical Solution | Teva | used to treat adult males who have low or no testosterone due to certain medical conditions | 8/18/2017 |
Seroquel XR | AstraZeneca | Quetiapine Fumarate ER Tablets | Lupin | used for the treatment of schizophrenia; acute manic or mixed episodes in bipolar I disorder alone or as an adjunct to lithium or divalproex; acute depressive episodes in bipolar disorder; maintenance treatment of bipolar I disorder, as an adjunct to lithium or divalproex and as an adjunctive therapy to antidepressants for the treatment of major depressive disorder | 8/23/2017 |
Suprax | Astellas | Cefixime for Oral Suspension | Dr. Reddy's Laboratories | used in the treatment of adults and pediatric patients six months of age or older with the following infections when caused by susceptible isolates of the designated bacteria: Uncomplicated Urinary Tract Infections; Otitis Media; Pharyngitis and Tonsillitis; Acute Exacerbations of Chronic Bronchitis; Uncomplicated Gonorrhea (cervical/urethral) | 8/28/2017 |
Sabril | Lundbeck | Vigabatrin for oral solution | Endo | used with other treatments in adults and children 10 years of age and older with refractory complex partial seizures (CPS) who have not responded well enough to several other treatments and if the possible benefits outweigh the risk of vision loss | 8/28/2017 |
Relpax | Pfizer | Eletriptan Hydrobromide Tablets | Ajanta | used to treat migraines | 8/31/2017 |
Fosrenol | Shire | Lanthanum Carbonate Chewable Tablets | Lupin | used to reduce serum phosphate in patients with end stage renal disease (ESRD) | 8/31/2017 |
Oxycodone HCl | Lehigh Valley | Oxycodone HCl Tablets | ANI Pharmaceuticals | used for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate | 9/1/2017 |
Benicar | Daiichi Sankyo | Olmesartan Medoxomil Tablets | Lupin | used for the treatment of hypertension, alone or in combination with other antihypertensive agents, to lower blood pressure | 9/4/2017 |
Skelaxin | King Pharmaceuticals | Metaxalone Tablets | Dr. Reddy's Laboratories | used as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions | 9/6/2017 |
Wellbutrin XL | GlaxoSmithKline | Bupropion HCl ER Tablets | Dr. Reddy's Laboratories | used to treat adults with a certain type of depression called major depressive disorder, and for the prevention of autumn-winter seasonal depression (seasonal affective disorder) | 9/6/2017 |
Cancidas | Merck | Caspofungin Acetate for Injection | Fresenius Kabi USA | used in adults and pediatric patients (3 months of age and older) for: empirical therapy for presumed fungal infections in febrile, neutropenic patients; treatment of candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections; treatment of esophageal candidiasis and treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies | 9/12/2017 |
Urocit-K | Mission Pharma | Potassium Citrate ER Tablets | Strides Shasun | used for preventing certain types of kidney stones | 9/12/2017 |
Symmetrel | Upsher-Smith | Amantadine HCl IR Capsules | Heritage Pharmaceuticals | used for the treatment of influenza A virus infection and is also used in the treatment of Parkinson's | 9/14/2017 |
Minastrin 24 FE | Allergan | Norethindrone Acetate / Ethinyl Estradiol Tablets / Ferrous Fumarate Tablets | Mylan | used for use by women to prevent pregnancy | 9/14/2017 |
Lovaza | SmithKline Beecham | Omega-3-Acid Ethyl Esters Capsules | Strides Shasun | used as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia (HTG) | 9/20/2017 |
Nexium 24HR (OTC) | AstraZeneca | Esomeprazole Magnesium (OTC) | Perrigo | used to treat frequent heartburn (occurring 2 or more days a week) | 9/27/2017 |
Minastrin 24 FE | Allergan | Norethindrone Acetate / Ethinyl Estradiol / Ferrous Fumarate Capsules | Amneal | used for use by women to prevent pregnancy | 9/28/2017 |
Renvela | Genzyme Corp | Sevelamer Carbonate Tablets | Dr. Reddy's Laboratories | used to control phosphorus levels in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis | 9/29/2017 |
Gleevec | Novartis | Imatinib Mesylate Tablets | Mylan | used in newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase, etc. | 9/29/2017 |
GENERICally Speaking Fall 2017
Related Publications
September 18, 2024
Astellas Pharma, Inc. v. Sandoz Inc.
GENERICally Speaking Hatch Waxman Bulletin
September 9, 2024
Purdue Pharma L.P v. Accord Healthcare Inc.
GENERICally Speaking Hatch Waxman Bulletin
September 4, 2024
Exeltis USA, Inc. v. Lupin Ltd.
GENERICally Speaking Hatch Waxman Bulletin
August 28, 2024
Teva Branded Pharm. Products R&D, Inc. v. Deva Holding A.S.
GENERICally Speaking Hatch Waxman Bulletin
August 13, 2024
Allergan USA, Inc. v. MSN Labs. Private Ltd.
GENERICally Speaking Hatch Waxman Bulletin
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.